Literature DB >> 1603844

The mechanism of photosensitization in photodynamic therapy: chemiluminescence caused by photosensitization of porphyrins in saline containing human serum albumin.

T Takemura1, N Ohta, S Nakajima, I Sakata.   

Abstract

Chemiluminescence (CL) caused by photosensitization of porphyrins in phosphate buffered saline (PBS) solution containing 3% human serum albumin (HSA) was observed for the first time. Irrespective of porphyrins concerned, CL shows a spectrum ranging from 380 to 520 nm with a peak near 450 nm and decays almost single-exponentially with a lifetime of about 15 s. The intensity of CL depends on concentrations of porphyrins and HSA in PBS solution. We have examined a number of porphyrins and observed CL for the compounds with triplet lifetimes longer than 0.1 ms. The appearance and quenching of CL by photosensitization of porphyrin-HSA systems indicate that type II reaction by singlet oxygen occurs significantly in photodynamic therapy resulting in hypoxic regions in environments surrounding the sensitizer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1603844     DOI: 10.1111/j.1751-1097.1992.tb04220.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  4 in total

1.  Combinatorial synthesis and modification of functional porphyrin libraries: identification of new, amphipathic motifs for biomolecule binding.

Authors:  C M Drain; X Gong; V Ruta; C E Soll; P F Chicoineau
Journal:  J Comb Chem       Date:  1999 Jul-Aug

2.  Photodynamic inactivation of fibroblasts by a cationic porphyrin.

Authors:  Saskia A G Lambrechts; Kevin R Schwartz; Maurice C G Aalders; Jacob B Dankert
Journal:  Lasers Med Sci       Date:  2005-06-07       Impact factor: 3.161

3.  Fluorinated Photodynamic Therapy Device Tips and their Resistance to Fouling for In Vivo Sensitizer Release.

Authors:  Ashwini A Ghogare; Joann M Miller; Bikash Mondal; Alan M Lyons; Keith A Cengel; Theresa M Busch; Alexander Greer
Journal:  Photochem Photobiol       Date:  2015-11-04       Impact factor: 3.421

4.  Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.

Authors:  Y Takehara; H Sakahara; H Masunaga; S Isogai; N Kodaira; H Takeda; T Saga; S Nakajima; I Sakata
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.